Tailored treatment strategies for obstructive sleep apnea

Respir Investig. 2016 Jan;54(1):2-7. doi: 10.1016/j.resinv.2015.09.007. Epub 2015 Dec 8.

Abstract

Obstructive sleep apnea (OSA) is characterized by repetitive collapse of the upper airway (UA) during sleep and is associated with chronic intermittent hypoxemia, catecholamine surges, and sleep disrupt. Multiple pathophysiological risk factors have been identified and contribute to OSA, including anatomical abnormalities (elevated UA mechanical load), compromised UA dilators, increased loop gain (unstable respiratory control), and decreased arousal threshold. These factors may contribute to the pathophysiology of sleep apnea in different individuals and recent evidence suggests that treatment may be targeted towards underlying pathophysiological mechanism. In some cases, combination therapy may be required to treat the condition.

Keywords: Airway; Apnea; Lung; Muscle; Sleep.

Publication types

  • Review

MeSH terms

  • Arousal
  • Catecholamines / metabolism
  • Chronic Disease
  • Combined Modality Therapy
  • Continuous Positive Airway Pressure
  • Humans
  • Hypoxia / etiology
  • Pharynx / physiopathology
  • Precision Medicine*
  • Risk Factors
  • Sleep Apnea, Obstructive / etiology
  • Sleep Apnea, Obstructive / physiopathology
  • Sleep Apnea, Obstructive / therapy*

Substances

  • Catecholamines